Reduced Phosphorylation of Transcription Factor Elk-1 in Cultured Fibroblasts of a Patient with Premature Aging Syndrome and Insulin Resistance

Abstract

The effect of insulin and growth factor mediated signaling to gene regulation was investigated in cultured fibroblasts of a patient with a premature aging syndrome (metageria) and severe insulin resistance. Insulin receptor structure and function as well as major pathways activated by insulin, i.e. phosphatidyl inositol‐3 kinase (PI-3 K) cascade or mitogen-activated protein kinase (MAPK) cascades, were functional. Inducibility of the proto-oncogene cfos, a representative endpoint of signaling pathways related to gene expression, by growth factors or insulin was reduced in patient cells. This reduced induction persisted in cfos promoter reporter gene studies indicating that the post receptor defect is localized proximal to the cfos promoter itself. Abundances of the transcription factors Elk-1 and SRF being major players in coupling of MAPKs to cfos promoter activation were not altered. However, basal and inducible phosphorylation of Elk-1 was impaired. In addition, basal and stimulated transcriptional activity mediated by Elk-1 was almost abolished in patient cells. Therefore these results identify a post receptor defect in cFos induction, which appears to be related to a functional alteration of Elk-1. A possible relation of this signal transduction defect to the specific premature aging syndrome remains to be elucidated.

Insulin resistance - signal transduction - cFos promoter - transcription factor Elk-1 - premature aging

References

• 1 Buchwalter G, Gross C, Wasylyk B. Ets ternary complex transcription factors.  Gene. 2004;  324 1-14
• 2 Chang L, Karin M. Mammalian MAP kinase signalling cascades.  Nature. 2001;  410 37-40
• 3 Cheatham B, Kahn C R. Insulin action and insulin signaling network.  Endocrine Reviews. 1996;  16 117-142
• 4 Cruzalegui F H, Cano E, Treisman R. ERK activation induces phosphorylation of Elk-1 at multiple S/T-P motivs to high stoichiometriy.  Oncogene. 1999;  18 7948-7954
• 5 Dyer C AE, Sinclair A J. The premature aging syndromes: insights into the aging process.  Age and Aging. 1998;  27 73-80
• 6 Fulop T, Larbi A, Douziech N. Insulin receptor and aging.  Pathol Biol. 2003;  51 574-580
• 7 Kresten S, Cesvergne B, Wahli W. Role of PPARs in health and disease.  Nature. 2000;  405 421-424
• 8 Griffiths M R, Black E J, Culbert A A, Dickens M, Shaw P E, Gillespie D A, Tavare J M. Insulin-stimulated expression of cfos, fra1 and c-jun accompanies the activation of the activator protein-1 (AP-1) transcriptional complex.  Biochem J. 1998;  335 19-26
• 9 Hadara S, Smith R M, Smith J A, White M F, Jarett L. Insulin-induced erg-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinasotol 3-kinase activation.  J Biol Chem. 1996;  271 30222-30336
• 10 Hunzelmann N, Ueberkam U, Eckes B, Herrmann K, Krieg T. Transforming growth factor-beta reverses deficient expression of type (I) collagene in cultured fibroblasts of a patient with metageria.  Biochimica et Biophysica Acta. 1997;  1360 64-70
• 11 Kaufmann I, Thiele B, Mahrle G. Metageria and Acrogeria Groton in one family.  Z Hautkr. 1985;  60 975-984
• 12 Knebel B, Kotzka J, Avci H, Schiller M, Brüning J, Hafner M, Krone W, Müller-Wieland D. Characterization of a postreceptor signaling defect that impairs cfos expression in cultured fibroblasts of a patient with insulin resistance.  Biophys Biochem Res Commun. 2000;  268 577-582
• 13 Li Q-J, Yang S-H, Maeda Y, Sladek F M, Sharrocks A D, Martins-Green M. MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300.  EMBO J. 2003;  22 281-291
• 14 Mauviel A, Koroung K, Santvah M, Tewari D, Uitto J, Iozzo R. Identification of a bimodular regulatory element encompassing a canonical AP-1 binding site in the proximal promoter region of the human decorin gene.  J Biol Chem. 1995;  270 11692-11700
• 15 Mitsuuchi Y, Johnson S W, Moonblatt S, Testa J R. Translocation and activation of Akt2 in response to stimulation by insulin.  J Cell Biochem. 1998;  70 433-441
• 16 Oshima J, Campisi J, Tannock T CA, Martin G. Regulation of cfos expression in senescing Werner syndrome fibroblasts differs from that observed in senescing fibroblasts from normal donors.  J Cell Physiol. 1995;  162 277-283
• 17 Sharrocks A D. Complexities in ETS-domain transcription factor function and regulation; lessons from the TCF subfamily.  Biochem Soc Trans. 2002;  30 1-9
• 18 Shaw P E, Saxton J. Ternary complex factors: prime nuclear targets for mitogen-activated protein kinases.  Int J Biochem Cell Biol. 2003;  35 1210-1226
• 19 Siemeister G, Al-Hasani H, Klein W, Kellner S, Streicher R, Krone W, Müller-Wieland D. Recombinant human insulin receptor substrate-1 protein.  J Biol Chem. 1995;  270 4870-4874
• 20 Soutar A K. Update on low density lipoprotein receptor mutations.  Curr Oppin Lipidol. 1998;  2 141-147
• 21 Taylor S I, Accili D, Haft C R, Hone J, Imai Y, Levy-Toledano R, Quon M J, Suzuki Y, Wertheimer E. Mechanisms of hormone resistance: lessons from insulin resistant patients.  Acta Paediatr. 1994;  399 (Suppl) 95-104
• 22 Uotani S, Yamaguchi Y, Yokota A, Yamasaki H, Takino H, Chikuba N, Goto Y, Fujishima N, Yano M, Matsumoto K. Molecular analysis of insulin receptor gene in Werner's syndrome.  Diabetes Res Clin Pract. 1994;  26 171-176
• 23 Yang S-H, Withmarsh A J, Davis R J, Sharrocks A D. Differential targeting of MAP kinases to the Ets-domain transcription factor Elk-1.  Mol Cell Biol. 1998;  18 710-720
• 24 Yang S H, Sharrocks A D, Withmarsh A J. Transcriptional regulation by the MAP kinase signaling cascades.  Gene. 2003 a;  321 3-21
• 25 Yang S-H, Jaffray E, Hay R T, Sharrocks A D. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity.  Molecular Cell. 2003 b;  12 63-74
• 26 Winkels J A, O'Conner M L, Friesel R. Altered regulation of platelet-derived growth factor A chain and cfos gene expression in senescent progeria fibroblasts.  J Cell Physiol. 1990;  144 313-325